|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: SYT7 |
Gene summary for SYT7 |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | SYT7 | Gene ID | 9066 |
| Gene name | synaptotagmin 7 | |
| Gene Alias | IPCA-7 | |
| Cytomap | 11q12.2 | |
| Gene Type | protein-coding | GO ID | GO:0001505 | UniProtAcc | O43581 |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 9066 | SYT7 | HTA11_78_2000001011 | Human | Colorectum | AD | 2.21e-04 | 2.55e-01 | -0.1088 |
| 9066 | SYT7 | HTA11_411_2000001011 | Human | Colorectum | SER | 1.29e-05 | 7.31e-01 | -0.2602 |
| 9066 | SYT7 | HTA11_2112_2000001011 | Human | Colorectum | SER | 3.83e-04 | 4.09e-01 | -0.2196 |
| 9066 | SYT7 | HTA11_3361_2000001011 | Human | Colorectum | AD | 3.43e-03 | 1.65e-01 | -0.1207 |
| 9066 | SYT7 | HTA11_866_3004761011 | Human | Colorectum | AD | 8.49e-04 | 8.53e-02 | 0.096 |
| 9066 | SYT7 | HTA11_10711_2000001011 | Human | Colorectum | AD | 7.45e-03 | 1.29e-01 | 0.0338 |
| 9066 | SYT7 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 1.44e-05 | 2.30e-01 | 0.294 |
| 9066 | SYT7 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 1.98e-04 | 1.65e-01 | 0.281 |
| 9066 | SYT7 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 4.94e-29 | 6.45e-01 | 0.3859 |
| 9066 | SYT7 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 3.17e-30 | 5.94e-01 | 0.3005 |
| 9066 | SYT7 | A002-C-021 | Human | Colorectum | FAP | 4.63e-03 | 1.46e-01 | 0.1171 |
| 9066 | SYT7 | A001-C-007 | Human | Colorectum | CRC | 9.19e-03 | 3.15e-01 | 0.1899 |
| 9066 | SYT7 | CRC-3-11773 | Human | Colorectum | CRC | 3.19e-02 | 2.03e-01 | 0.2564 |
| 9066 | SYT7 | P26T-E | Human | Esophagus | ESCC | 3.52e-02 | 1.63e-02 | 0.1276 |
| 9066 | SYT7 | P28T-E | Human | Esophagus | ESCC | 3.49e-08 | 9.54e-02 | 0.1149 |
| 9066 | SYT7 | P37T-E | Human | Esophagus | ESCC | 2.95e-26 | 6.38e-01 | 0.1371 |
| 9066 | SYT7 | P44T-E | Human | Esophagus | ESCC | 9.23e-06 | 2.12e-01 | 0.1096 |
| 9066 | SYT7 | P47T-E | Human | Esophagus | ESCC | 4.94e-04 | 3.26e-02 | 0.1067 |
| 9066 | SYT7 | P74T-E | Human | Esophagus | ESCC | 1.24e-03 | 1.41e-01 | 0.1479 |
| 9066 | SYT7 | P75T-E | Human | Esophagus | ESCC | 5.42e-03 | 5.64e-02 | 0.1125 |
| Page: 1 2 3 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Colorectum (GSE201348) |  | FAP: Familial adenomatous polyposis |
| CRC: Colorectal cancer | ||
| Colorectum (HTA11) |  | AD: Adenomas |
| SER: Sessile serrated lesions | ||
| MSI-H: Microsatellite-high colorectal cancer | ||
| MSS: Microsatellite stable colorectal cancer | ||
| Esophagus |  | ESCC: Esophageal squamous cell carcinoma |
| HGIN: High-grade intraepithelial neoplasias | ||
| LGIN: Low-grade intraepithelial neoplasias | ||
| Liver |  | HCC: Hepatocellular carcinoma |
| NAFLD: Non-alcoholic fatty liver disease | ||
| Prostate |  | BPH: Benign Prostatic Hyperplasia |
| Thyroid |  | ATC: Anaplastic thyroid cancer |
| HT: Hashimoto's thyroiditis | ||
| PTC: Papillary thyroid cancer |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| GO:0016482 | Colorectum | AD | cytosolic transport | 68/3918 | 168/18723 | 6.00e-09 | 3.72e-07 | 68 |
| GO:0016050 | Colorectum | AD | vesicle organization | 101/3918 | 300/18723 | 1.65e-07 | 7.17e-06 | 101 |
| GO:0042060 | Colorectum | AD | wound healing | 128/3918 | 422/18723 | 2.73e-06 | 7.89e-05 | 128 |
| GO:0050708 | Colorectum | AD | regulation of protein secretion | 83/3918 | 268/18723 | 6.59e-05 | 1.07e-03 | 83 |
| GO:0009306 | Colorectum | AD | protein secretion | 105/3918 | 359/18723 | 1.05e-04 | 1.57e-03 | 105 |
| GO:0035592 | Colorectum | AD | establishment of protein localization to extracellular region | 105/3918 | 360/18723 | 1.18e-04 | 1.73e-03 | 105 |
| GO:0045921 | Colorectum | AD | positive regulation of exocytosis | 33/3918 | 86/18723 | 1.58e-04 | 2.20e-03 | 33 |
| GO:0071692 | Colorectum | AD | protein localization to extracellular region | 106/3918 | 368/18723 | 1.86e-04 | 2.49e-03 | 106 |
| GO:0050796 | Colorectum | AD | regulation of insulin secretion | 54/3918 | 165/18723 | 2.60e-04 | 3.25e-03 | 54 |
| GO:0010038 | Colorectum | AD | response to metal ion | 106/3918 | 373/18723 | 3.22e-04 | 3.83e-03 | 106 |
| GO:0051047 | Colorectum | AD | positive regulation of secretion | 90/3918 | 310/18723 | 4.11e-04 | 4.66e-03 | 90 |
| GO:0030073 | Colorectum | AD | insulin secretion | 61/3918 | 195/18723 | 4.28e-04 | 4.81e-03 | 61 |
| GO:0071248 | Colorectum | AD | cellular response to metal ion | 61/3918 | 197/18723 | 5.74e-04 | 6.09e-03 | 61 |
| GO:1903532 | Colorectum | AD | positive regulation of secretion by cell | 82/3918 | 282/18723 | 6.85e-04 | 7.00e-03 | 82 |
| GO:0071241 | Colorectum | AD | cellular response to inorganic substance | 68/3918 | 226/18723 | 6.98e-04 | 7.10e-03 | 68 |
| GO:0015833 | Colorectum | AD | peptide transport | 77/3918 | 264/18723 | 8.90e-04 | 8.60e-03 | 77 |
| GO:0010876 | Colorectum | AD | lipid localization | 120/3918 | 448/18723 | 1.59e-03 | 1.33e-02 | 120 |
| GO:0006869 | Colorectum | AD | lipid transport | 108/3918 | 398/18723 | 1.67e-03 | 1.39e-02 | 108 |
| GO:0090087 | Colorectum | AD | regulation of peptide transport | 60/3918 | 202/18723 | 1.94e-03 | 1.58e-02 | 60 |
| GO:0030072 | Colorectum | AD | peptide hormone secretion | 68/3918 | 236/18723 | 2.39e-03 | 1.85e-02 | 68 |
| Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| SYT7 | SNV | Missense_Mutation | novel | c.1253C>T | p.Thr418Met | p.T418M | O43581 | protein_coding | tolerated(0.23) | benign(0.02) | TCGA-AC-A3W6-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
| SYT7 | SNV | Missense_Mutation | c.730N>A | p.Gly244Ser | p.G244S | O43581 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AQ-A1H3-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | SD | |
| SYT7 | SNV | Missense_Mutation | novel | c.621C>G | p.Ser207Arg | p.S207R | O43581 | protein_coding | tolerated(0.4) | possibly_damaging(0.452) | TCGA-B6-A0IC-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
| SYT7 | SNV | Missense_Mutation | novel | c.752A>G | p.Lys251Arg | p.K251R | O43581 | protein_coding | tolerated(0.1) | benign(0.255) | TCGA-BH-A0B1-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | adriamycin | SD |
| SYT7 | insertion | Nonsense_Mutation | novel | c.622_623insTCTGAAATAAGCAAG | p.Arg208delinsLeuTerAsnLysGlnGly | p.R208delinsL*NKQG | O43581 | protein_coding | TCGA-B6-A0IC-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
| SYT7 | insertion | Nonsense_Mutation | novel | c.749_750insGATTAAGGAGTGATTTCTATCCCAGGGCCTTTGGGTGC | p.Lys251IlefsTer4 | p.K251Ifs*4 | O43581 | protein_coding | TCGA-BH-A0B1-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | adriamycin | SD | ||
| SYT7 | SNV | Missense_Mutation | novel | c.1393N>T | p.Arg465Cys | p.R465C | O43581 | protein_coding | deleterious(0) | possibly_damaging(0.852) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
| SYT7 | SNV | Missense_Mutation | rs550321037 | c.1237N>A | p.Ala413Thr | p.A413T | O43581 | protein_coding | tolerated(0.46) | benign(0.01) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
| SYT7 | SNV | Missense_Mutation | c.907C>T | p.Arg303Cys | p.R303C | O43581 | protein_coding | deleterious(0) | probably_damaging(0.993) | TCGA-C5-A1BF-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | PD | |
| SYT7 | SNV | Missense_Mutation | rs567302490 | c.1132G>T | p.Asp378Tyr | p.D378Y | O43581 | protein_coding | deleterious(0.01) | probably_damaging(1) | TCGA-EA-A3HQ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
| Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |